Global Long-acting Reversible Contraceptives (LARCs) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 111

Published Date: 29 Apr 2022

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Long-acting Reversible Contraceptives (LARCs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Long-acting Reversible Contraceptives (LARCs) market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Age 20-24 accounting for % of the Long-acting Reversible Contraceptives (LARCs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hormonal Intrauterine Devices segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Long-acting Reversible Contraceptives (LARCs) include Bayer, Merck, Cooper Companies, AbbVie Allergan, and Yantai JiShengYaoXie, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Long-acting Reversible Contraceptives (LARCs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Hormonal Intrauterine Devices
    Copper Intrauterine Devices
    Contraceptive Implants
    Others

Market segment by Application can be divided into
    Age 20-24
    Age 25-34
    Age 35-44
    Others

The key market players for global Long-acting Reversible Contraceptives (LARCs) market are listed below:
    Bayer
    Merck
    Cooper Companies
    AbbVie Allergan
    Yantai JiShengYaoXie
    H & J Medical
    HRA Pharma
    Pregna
    ASPIVIX
    Shanghai Dahua Pharmaceuticals
    Williams Medical Supplies
    Laboratoire 7 MED
    Durbin
    Laboratoire CCD
    Prosan
    OCON

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-acting Reversible Contraceptives (LARCs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Long-acting Reversible Contraceptives (LARCs), with price, sales, revenue and global market share of Long-acting Reversible Contraceptives (LARCs) from 2019 to 2022.
Chapter 3, the Long-acting Reversible Contraceptives (LARCs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting Reversible Contraceptives (LARCs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Long-acting Reversible Contraceptives (LARCs) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long-acting Reversible Contraceptives (LARCs).
Chapter 13, 14, and 15, to describe Long-acting Reversible Contraceptives (LARCs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Long-acting Reversible Contraceptives (LARCs) Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Hormonal Intrauterine Devices
        1.2.3 Copper Intrauterine Devices
        1.2.4 Contraceptive Implants
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Age 20-24
        1.3.3 Age 25-34
        1.3.4 Age 35-44
        1.3.5 Others
    1.4 Global Long-acting Reversible Contraceptives (LARCs) Market Size & Forecast
        1.4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume (2017-2028)
        1.4.3 Global Long-acting Reversible Contraceptives (LARCs) Price (2017-2028)
    1.5 Global Long-acting Reversible Contraceptives (LARCs) Production Capacity Analysis
        1.5.1 Global Long-acting Reversible Contraceptives (LARCs) Total Production Capacity (2017-2028)
        1.5.2 Global Long-acting Reversible Contraceptives (LARCs) Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Long-acting Reversible Contraceptives (LARCs) Market Drivers
        1.6.2 Long-acting Reversible Contraceptives (LARCs) Market Restraints
        1.6.3 Long-acting Reversible Contraceptives (LARCs) Trends Analysis

2 Manufacturers Profiles
    2.1 Bayer
        2.1.1 Bayer Details
        2.1.2 Bayer Major Business
        2.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Cooper Companies
        2.3.1 Cooper Companies Details
        2.3.2 Cooper Companies Major Business
        2.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 AbbVie Allergan
        2.4.1 AbbVie Allergan Details
        2.4.2 AbbVie Allergan Major Business
        2.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Yantai JiShengYaoXie
        2.5.1 Yantai JiShengYaoXie Details
        2.5.2 Yantai JiShengYaoXie Major Business
        2.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 H & J Medical
        2.6.1 H & J Medical Details
        2.6.2 H & J Medical Major Business
        2.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 HRA Pharma
        2.7.1 HRA Pharma Details
        2.7.2 HRA Pharma Major Business
        2.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Pregna
        2.8.1 Pregna Details
        2.8.2 Pregna Major Business
        2.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 ASPIVIX
        2.9.1 ASPIVIX Details
        2.9.2 ASPIVIX Major Business
        2.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Shanghai Dahua Pharmaceuticals
        2.10.1 Shanghai Dahua Pharmaceuticals Details
        2.10.2 Shanghai Dahua Pharmaceuticals Major Business
        2.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Williams Medical Supplies
        2.11.1 Williams Medical Supplies Details
        2.11.2 Williams Medical Supplies Major Business
        2.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Laboratoire 7 MED
        2.12.1 Laboratoire 7 MED Details
        2.12.2 Laboratoire 7 MED Major Business
        2.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Durbin
        2.13.1 Durbin Details
        2.13.2 Durbin Major Business
        2.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Laboratoire CCD
        2.14.1 Laboratoire CCD Details
        2.14.2 Laboratoire CCD Major Business
        2.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Prosan
        2.15.1 Prosan Details
        2.15.2 Prosan Major Business
        2.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 OCON
        2.16.1 OCON Details
        2.16.2 OCON Major Business
        2.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
        2.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Long-acting Reversible Contraceptives (LARCs) Breakdown Data by Manufacturer
    3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Long-acting Reversible Contraceptives (LARCs)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Long-acting Reversible Contraceptives (LARCs) Manufacturer Market Share in 2021
        3.4.2 Top 6 Long-acting Reversible Contraceptives (LARCs) Manufacturer Market Share in 2021
    3.5 Global Long-acting Reversible Contraceptives (LARCs) Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Long-acting Reversible Contraceptives (LARCs) Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region
        4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2017-2028)
        4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2028)
    4.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028)
    4.3 Europe Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028)
    4.4 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028)
    4.5 South America Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028)
    4.6 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Type (2017-2028)
    5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
    5.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Application (2017-2028)
    6.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
    6.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
    7.2 North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
    7.3 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        7.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2017-2028)
        7.3.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
    8.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
    8.3 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        8.3.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2017-2028)
        8.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
    9.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
    9.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Region
        9.3.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
    10.2 South America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
    10.3 South America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        10.3.1 South America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2017-2028)
        10.3.2 South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
    11.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
    11.3 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country
        11.3.1 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Long-acting Reversible Contraceptives (LARCs) and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Long-acting Reversible Contraceptives (LARCs)
    12.3 Long-acting Reversible Contraceptives (LARCs) Production Process
    12.4 Long-acting Reversible Contraceptives (LARCs) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Long-acting Reversible Contraceptives (LARCs) Typical Distributors
    13.3 Long-acting Reversible Contraceptives (LARCs) Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Bayer Basic Information, Manufacturing Base and Competitors
    Table 4. Bayer Major Business
    Table 5. Bayer Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 6. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Merck Basic Information, Manufacturing Base and Competitors
    Table 8. Merck Major Business
    Table 9. Merck Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 10. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Cooper Companies Basic Information, Manufacturing Base and Competitors
    Table 12. Cooper Companies Major Business
    Table 13. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 14. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. AbbVie Allergan Basic Information, Manufacturing Base and Competitors
    Table 16. AbbVie Allergan Major Business
    Table 17. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 18. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Yantai JiShengYaoXie Basic Information, Manufacturing Base and Competitors
    Table 20. Yantai JiShengYaoXie Major Business
    Table 21. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 22. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. H & J Medical Basic Information, Manufacturing Base and Competitors
    Table 24. H & J Medical Major Business
    Table 25. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 26. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. HRA Pharma Basic Information, Manufacturing Base and Competitors
    Table 28. HRA Pharma Major Business
    Table 29. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 30. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Pregna Basic Information, Manufacturing Base and Competitors
    Table 32. Pregna Major Business
    Table 33. Pregna Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 34. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. ASPIVIX Basic Information, Manufacturing Base and Competitors
    Table 36. ASPIVIX Major Business
    Table 37. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 38. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. Shanghai Dahua Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 40. Shanghai Dahua Pharmaceuticals Major Business
    Table 41. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 42. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Williams Medical Supplies Basic Information, Manufacturing Base and Competitors
    Table 44. Williams Medical Supplies Major Business
    Table 45. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 46. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. Laboratoire 7 MED Basic Information, Manufacturing Base and Competitors
    Table 48. Laboratoire 7 MED Major Business
    Table 49. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 50. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Durbin Basic Information, Manufacturing Base and Competitors
    Table 52. Durbin Major Business
    Table 53. Durbin Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 54. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 55. Laboratoire CCD Basic Information, Manufacturing Base and Competitors
    Table 56. Laboratoire CCD Major Business
    Table 57. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 58. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 59. Prosan Basic Information, Manufacturing Base and Competitors
    Table 60. Prosan Major Business
    Table 61. Prosan Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 62. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 63. OCON Basic Information, Manufacturing Base and Competitors
    Table 64. OCON Major Business
    Table 65. OCON Long-acting Reversible Contraceptives (LARCs) Product and Services
    Table 66. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 67. Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 68. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 69. Market Position of Manufacturers in Long-acting Reversible Contraceptives (LARCs), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 70. Global Long-acting Reversible Contraceptives (LARCs) Production Capacity by Company, (K Units): 2020 VS 2021
    Table 71. Head Office and Long-acting Reversible Contraceptives (LARCs) Production Site of Key Manufacturer
    Table 72. Long-acting Reversible Contraceptives (LARCs) New Entrant and Capacity Expansion Plans
    Table 73. Long-acting Reversible Contraceptives (LARCs) Mergers & Acquisitions in the Past Five Years
    Table 74. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
    Table 75. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2023-2028) & (K Units)
    Table 76. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (USD Million)
    Table 77. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028) & (USD Million)
    Table 78. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 79. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 80. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (USD Million)
    Table 81. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (USD Million)
    Table 82. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2022) & (US$/Unit)
    Table 83. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2023-2028) & (US$/Unit)
    Table 84. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 85. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 86. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (USD Million)
    Table 87. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (USD Million)
    Table 88. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2022) & (US$/Unit)
    Table 89. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2023-2028) & (US$/Unit)
    Table 90. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 91. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
    Table 92. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (USD Million)
    Table 93. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (USD Million)
    Table 94. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 95. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 96. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 97. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 98. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 99. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
    Table 100. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (USD Million)
    Table 101. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (USD Million)
    Table 102. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 103. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 104. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 105. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 106. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
    Table 107. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2023-2028) & (K Units)
    Table 108. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (USD Million)
    Table 109. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028) & (USD Million)
    Table 110. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 111. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 112. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 113. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 114. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 115. South America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
    Table 116. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (USD Million)
    Table 117. South America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (USD Million)
    Table 118. South America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 119. South America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 120. South America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 121. South America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 122. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
    Table 123. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Region (2023-2028) & (K Units)
    Table 124. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (USD Million)
    Table 125. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028) & (USD Million)
    Table 126. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 127. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
    Table 128. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
    Table 129. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
    Table 130. Long-acting Reversible Contraceptives (LARCs) Raw Material
    Table 131. Key Manufacturers of Long-acting Reversible Contraceptives (LARCs) Raw Materials
    Table 132. Direct Channel Pros & Cons
    Table 133. Indirect Channel Pros & Cons
    Table 134. Long-acting Reversible Contraceptives (LARCs) Typical Distributors
    Table 135. Long-acting Reversible Contraceptives (LARCs) Typical Customers
List of Figures
    Figure 1. Long-acting Reversible Contraceptives (LARCs) Picture
    Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type in 2021
    Figure 3. Hormonal Intrauterine Devices
    Figure 4. Copper Intrauterine Devices
    Figure 5. Contraceptive Implants
    Figure 6. Others
    Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application in 2021
    Figure 8. Age 20-24
    Figure 9. Age 25-34
    Figure 10. Age 35-44
    Figure 11. Others
    Figure 12. Global Long-acting Reversible Contraceptives (LARCs) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales (2017-2028) & (K Units)
    Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Price (2017-2028) & (US$/Unit)
    Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Production Capacity (2017-2028) & (K Units)
    Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Production Capacity by Geographic Region: 2022 VS 2028
    Figure 18. Long-acting Reversible Contraceptives (LARCs) Market Drivers
    Figure 19. Long-acting Reversible Contraceptives (LARCs) Market Restraints
    Figure 20. Long-acting Reversible Contraceptives (LARCs) Market Trends
    Figure 21. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturer in 2021
    Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturer in 2021
    Figure 23. Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 24. Top 3 Long-acting Reversible Contraceptives (LARCs) Manufacturer (Revenue) Market Share in 2021
    Figure 25. Top 6 Long-acting Reversible Contraceptives (LARCs) Manufacturer (Revenue) Market Share in 2021
    Figure 26. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2028)
    Figure 27. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2028)
    Figure 28. North America Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (USD Million)
    Figure 29. Europe Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (USD Million)
    Figure 30. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (USD Million)
    Figure 31. South America Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (USD Million)
    Figure 32. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (USD Million)
    Figure 33. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
    Figure 34. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
    Figure 35. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2028) & (US$/Unit)
    Figure 36. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 37. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
    Figure 38. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
    Figure 40. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 41. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2028)
    Figure 42. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2028)
    Figure 43. United States Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Canada Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 46. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
    Figure 47. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 48. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2028)
    Figure 49. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2028)
    Figure 50. Germany Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. France Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. United Kingdom Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Russia Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Italy Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2028)
    Figure 56. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 57. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2028)
    Figure 58. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2028)
    Figure 59. China Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Japan Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Korea Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. India Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. Southeast Asia Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Australia Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
    Figure 66. South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 67. South America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2028)
    Figure 68. South America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2028)
    Figure 69. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
    Figure 72. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
    Figure 73. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2028)
    Figure 74. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2028)
    Figure 75. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Egypt Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. South Africa Long-acting Reversible Contraceptives (LARCs) Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. Manufacturing Cost Structure Analysis of Long-acting Reversible Contraceptives (LARCs) in 2021
    Figure 80. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
    Figure 81. Long-acting Reversible Contraceptives (LARCs) Industrial Chain
    Figure 82. Sales Channel: Direct Channel vs Indirect Channel
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON

Product Tags

long acting reversible contraceptives larcs

Long-acting Reversible Contraceptives (LARCs)

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>